Immunovant, Inc. 4

Immunovant CFO Tiago Girao sold 6,798 shares of Immunovant, Inc. common stock on 2026-07-23 at a weighted-average price of about $38.69 per share to cover taxes from RSU vesting.

On July 23, 2026, Immunovant, Inc. Chief Financial Officer Tiago Girao sold 6,798 shares of Immunovant common stock at a weighted-average price of approximately $38.69 per share, for proceeds of about $262,900, in a broker-assisted sale mandated to cover tax withholding obligations arising from the July 21, 2026 vesting of 13,024 RSUs from a May 1, 2025 grant. Following this automatic 'sell-to-cover' transaction, which the filing specifies was not a discretionary trade, Girao beneficially owns 240,798 shares of Immunovant common stock. The sale price reflects multiple trades executed between $38.18 and $39.05 per share.

Filing Facts

CIK

1764013

Ticker

IMVT

Form

4

Source Type

fda

Accession

0001618670-26-000004

Alert Tier

5